Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line (Q40833122)

24 September 2017

title

Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line (English)

1 reference

24 September 2017

1 reference

Fabry M

1

1 reference

24 September 2017

Cabrele C

series ordinal

2

1 reference

24 September 2017

Höcker H

series ordinal

3

1 reference

24 September 2017

Beck-Sickinger AG

series ordinal

4

1 reference

24 September 2017

publication date

1 December 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

21

1 reference

24 September 2017

issue

12

1 reference

24 September 2017

page(s)

1885-1893

1 reference

The IGF-I receptor in cancer research

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Growth factor receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Synthesis and characterization of photoreactive insulin-like growth factor 1 derivatives for receptor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Inhibition of human neuroblastoma growth by a specific VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Fluorescent ligands for the study of receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Beta-adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Functional insulin-like growth factor I receptors are expressed by neural-derived continuous cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Recombinant Toxins for Cancer Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

A fast and inexpensive method for N-terminal fluorescein-labeling of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900328-4

7 January 2021

10.1016/S0196-9781(00)00328-4

Identifiers

DOI

1 reference

24 September 2017

1 reference